The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders
Open accessThe DOI matches its Crossref record; 200 of the 202 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of psychiatric disorders. Primarily through its antioxidant, anti-inflammatory, and glutamate modulation activity, NAC has been investigated in the treatment of neurodevelopmental disorders, schizophrenia spectrum disorders, bipolar-related disorders, depressive disorders, anxiety disorders, obsessive compulsive-related disorders, substance-use disorders, neurocognitive disorders, and chronic pain. Whilst there is ample preclinical evidence and theoretical justification for the use of NAC in the treatment of multiple psychiatric disorders, clinical trials in most disorders have yielded mixed results. However, most studies have been underpowered and perhaps too brief, with some evidence of benefit only after months of treatment with NAC. Currently NAC has the most evidence of having a beneficial effect as an adjuvant agent in the negative symptoms of schizophrenia, severe autism, depression, and obsessive compulsive and related disorders. Future research with well-powered studies that are of sufficient length will be critical to better understand the utility of NAC in the treatment of psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As a result, the early intervention and the clinical staging models have encouraged investigations into more benign pharmacological treatments including “neutraceuticals”, that is, food or food products with health and medical benefits, such as fish oil [109], N-acetylcysteine [110], and cannabidiol [111], that may be suitable for targeting emerging psychopathology.”
From Towards a youth mental health paradigm: a perspective and roadmap (2023) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Rakita, A., Nikolić, N., Mildner, M., Matiasek, J., & Elbe-Bürger, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-56847-4 · Cited by 8,228
Yang (2021) · doi:10.1038/s41598-020-79139-8 · Cited by 5,035
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 1×
“10 Substance‐Use Disorders Chronic substance use results in changes to frontostriatal glutamatergic circuitry, resulting in compulsive alcohol/ drug seeking and loss of adaptive behavior in the presence of substance-associated environmental or interoceptive stimuli [133].”
BackgroundSelf-citationThe chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Self-citationN-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1468564 · Cited by 830
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739
Self-citationBerk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · cited 4×
“This pattern has also been seen in studies investigating NAC’s effect on bipolar disorder and schizophrenia [38, 46].”
BackgroundResultSelf-citationBerk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500
Self-citationN-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494
Self-citation
Research works printed but not linked: 1
- Zhang J Chen B Lu J Treatment effect of risperidone alone and combined with N-acetyl-cysteine for first-episode schizophrenic patients J Clin Psychiatry 2015 1005 394 396
Cited by
Towards a youth mental health paradigm: a perspective and roadmap
Uhlhaas, P. J., Davey, C. G., Mehta, U. M., Shah, J., Torous, J., Allen, N. B., Avenevoli, S., Bella-Awusah, T., Chanen, A., Chen, E. Y. H., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02202-z · Cited by 318
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Burback, L., Brémault-Phillips, S., Nijdam, M. J., McFarlane, A., & Vermetten, E. (2024) · Current Neuropharmacology · doi:10.2174/1570159x21666230428091433 · Cited by 208
Nicosia, N., Giovenzana, M., Misztak, P., Mingardi, J., & Musazzi, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126521 · Cited by 135
“…including antioxidant effects, reduction in cytokine activity, modulation of dopamine release, reversal of mitochondrial dysfunction, reduction in apoptosis, anti-inflammatory activity, increased neurogenesis, and regulation of glutamate homeostasis, has shown promising effects in ASD [45].”
BackgroundMitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 100
Weickert, T. W., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W. S., Brown, D. A., Pellen, D., Kindler, J., Mohan, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.10.012 · Cited by 48
Lee, D. K., & Lipner, S. R. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116370 · Cited by 47
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Sah, A., & Singewald, N. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108825 · Cited by 48
Poladian, N., Navasardyan, I., Narinyan, W., Orujyan, D., & Venketaraman, V. (2023) · Clinics and Practice · doi:10.3390/clinpract13040070 · Cited by 42
Yuan, L., Zhang, Q., Yu, L., Wu, Y., Wang, C., Shao, C., & Lu, S. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c01683 · Cited by 33
Mitochondrial and metabolic features of salugenesis and the healing cycle
Naviaux, R. K. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.04.003 · Cited by 32
Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics
Wolf, M. E. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080548 · Cited by 28
Role of epigenetics in the regulation of skin aging and geroprotective intervention: A new sight
Pozzo, L. D., Xu, Z., Lin, S., Wang, J., Wang, Y., Enechojo, O. S., Abankwah, J. K., Peng, Y., Chu, X., Zhou, H., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116592 · Cited by 26
Barlattani, T., Celenza, G., Cavatassi, A., Minutillo, F., Socci, V., Pinci, C., Santini, R., & Pacitti, F. (2024) · Current Neuropharmacology · doi:10.2174/011570159x343115241030094848 · Cited by 23
Glutamate-Based Therapeutic Strategies for Schizophrenia: Emerging Approaches Beyond Dopamine
Stănculete, M. F., & Căpățînă, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094331 · Cited by 22
Beer, C., Rae, F., Semmler, A., & Voisey, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147992 · Cited by 20
Grunze, H. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2266359 · Cited by 20
Progress in the mechanisms of pain associated with neurodegenerative diseases
Tian, Z., Zhang, Q., Wang, L., Li, M., Li, T., Wang, Y., Cao, Z., Jiang, X., & Luo, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102579 · Cited by 18
Parli, G. M., Gales, M. A., & Gales, B. J. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221138092 · Cited by 18
Kanaan, R., Oliver, G., Dharan, A. L., Sendi, S., Maier, A., Mohebbi, M., Ng, C. H., Back, S. E., Kalivas, P. W., & Berk, M. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115398 · Cited by 17
Self-citationGee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03221-2 · Cited by 16
Global Trends in the Use of Pharmacotherapy for the Treatment of Bipolar Disorder
Yocum, A. K., & Singh, B. (2025) · Current Psychiatry Reports · doi:10.1007/s11920-025-01606-8 · Cited by 16
Yang, K., Chen, Y., Liu, M., Yang, B., & Chou, Y.-H. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.09.022 · Cited by 15
Depression interacts with allostatic load to predict cognitive decline in middle age
Perlman, G., Cogo‐Moreira, H., Wu, C., Herrmann, N., & Swardfager, W. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105922 · Cited by 14
Romero‐Miguel, D., Casquero‐Veiga, M., Lamanna‐Rama, N., Torres-Sánchez, S., MacDowell, K. S., Garcia-Partida, J. A., Santa-Marta, C., Berrocoso, E., Leza, J. C., Desco, M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02652-7 · Cited by 14
Bühner, L. M., Kapanaiah, S. K. T., & Kätzel, D. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1002223 · Cited by 11
Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders
Weiss, F., Brancati, G. E., Elefante, C., Petrucci, A., Gemmellaro, T., Lattanzi, L., & Perugi, G. (2023) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000515 · Cited by 10
Samà, M., Musillo, C., & Cirulli, F. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.041 · Cited by 10
Felice, M. D., Szkudlarek, H. J., Uzuneser, T. C., Rodríguez-Ruiz, M., Sarikahya, M. H., Pusparajah, M., Lazo, J. P. G., Whitehead, S. N., Yeung, K. K. ‐., Rushlow, W. J., et al. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100361 · Cited by 10
Exploring Biological Risk Factors in Treatment-Resistant Depression
Lievanos-Ruiz, F. J., & Navarro, B. F. (2025) · Psychiatry International · doi:10.3390/psychiatryint6040134 · Cited by 9
Lai, C., Baskaran, R., Tsao, C.-Y., Tuan, L., Siow, P.-F., Palani, M., Lee, L. J., Liu, C., Hwu, H., & Lee, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169419 · Cited by 9
Pharmacological treatments for co-occurring PTSD and substance use disorders: A systematic review
Swannell, M., Bradlow, R. C. J., Pham, D., Gabriel, J., Manahan, Y., & Arunogiri, S. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209601 · Cited by 9
Self-citationYang, K., Yang, B., Lan, C., Liu, M., & Chou, Y.-H. (2024) · Psychological Medicine · doi:10.1017/s0033291724002228 · Cited by 9
Rodríguez, P. O., Ortega, D. R., Ayala, T. B., Roldán-Roldán, G., de la Cruz, G. P., González‐Esquivel, D. F., Gómez‐Manzo, S., Sánchez‐Chapul, L., Salazar, A., Pineda, B., et al. (2023) · Antioxidants · doi:10.3390/antiox12122035 · Cited by 9
A novel discovery platform for targeted drug repurposing: application for psychiatric disorders
Berk, M., Kim, J. H., Williams, L. J., Liu, Z. S.-J., Siskind, D. J., Panizzutti, B., Yung, A. R., & Walder, K. R. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00066-5 · Cited by 8
Self-citationIsorhapontigenin alleviates acetaminophen-induced liver injury by promoting fatty acid oxidation
Zha, H., Lv, S., Hu, Y., Xie, Y., Wang, L., Yang, C., Li, G., Gong, S., Li, P., Zhu, D., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167575 · Cited by 8
Bikal, P., & Bhardwaj, J. K. (2025) · Environmental Toxicology · doi:10.1002/tox.24505 · Cited by 8
Emerging Neurobiological and Therapeutic Insights into Schizophrenia: A Comprehensive Review
Oatu, A., Capatina, T.-F., Mandras, I.-C., Comșa, A. L., Trifu, S. C., & Pietreanu, A. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041906 · Cited by 7
Li, J., Jiang, L., Zhao, K., Tang, Y., Yuan, X., & Xu, Y. (2024) · Shock · doi:10.1097/shk.0000000000002438 · Cited by 7
Saati, A. A. (2025) · Brain Sciences · doi:10.3390/brainsci15030242 · Cited by 7
Nutrition for Mental Health: Guidance for Clinical Practice
Fenton, A., Neiling, K., Ndzi, M., Goode, C. K., & Humphrey, K. G. (2024) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2024.105209 · Cited by 6
Wasserthal, S., Muthesius, A., Hurlemann, R., Ruhrmann, S., Schmidt, S. J., Hellmich, M., Schultze‐Lutter, F., Klosterkötter, J., Müller, H., Meyer‐Lindenberg, A., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae005 · Cited by 6
Xiong, Z., Wang, H., Qu, Y., Peng, S., He, Y., Yang, Q., Xu, X., Lv, D., Liu, Y., Xie, C., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110831 · Cited by 5
Prophylactic Effects of n-Acethylcysteine on Inflammation-induced Depression-like Behaviors in Mice
Wang, Z., Hu, Q., Tian, C., Wang, R., Jiao, Q., Chen, F., Wu, T., Wang, J., Zhu, Y., Liu, A., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.005 · Cited by 5
Pawlik, P., Kurzawińska, G., Ożarowski, M., Wolski, H., Piątek, K., Słopień, R., Sajdak, S., Olbromski, P. J., & Seremak‐Mrozikiewicz, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612574 · Cited by 5
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Neurochemical Journal · doi:10.1134/s1819712423040086 · Cited by 5
Freitas, I. D. S., Guimarães, F. S., & Gomes, F. V. (2025) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaf029 · Cited by 4
Patel, S. R., Tareen, K., Patel, C. B., & Rosinski, A. B. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01517-0 · Cited by 4
Musillo, C., Samà, M. T., Creutzberg, K. C., Begni, V., Collacchi, B., Bitraj, J., Collo, G., Riva, M. A., Berry, A., & Cirulli, F. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03530-0 · Cited by 4
Hou, Y., Park, J. H., Dan, X., Chu, X., Yang, B., Hussain, M., Croteau, D. L., & Bohr, V. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106092 · Cited by 3
Chronic Pain and Obsessive–Compulsive Disorder: A Scoping Review
Sloley, C., Bell, C., Shipton, E. A., Williman, J. A., & Jarvis, J. L. (2025) · Pain and Therapy · doi:10.1007/s40122-024-00704-4 · Cited by 3
Lin, C., & Lane, H. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.11.010 · Cited by 3
Arjmand, S., Ilaghi, M., Shafie’ei, M., Gobira, P. H., Grassi‐Oliveira, R., & Wegener, G. (2024) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.38 · Cited by 3
The Emerging Role of N-Acetylcysteine in Psychiatry: A Narrative Review of Available Data
Marazziti, D., Caruso, V., Cappellato, G., Chiarantini, I., Gurrieri, R., Perrone, P., Violi, M., Crivelli, N. S. B., Weiss, F., & Perugi, G. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673365458250901115725 · Cited by 3
Muthmainah, M., Wiyono, N., Syah, F. K., Purnianto, A., Yudhani, R. D., & Wasita, B. (2025) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2025.05.004 · Cited by 2
N-Acetylcysteine (NAC) for Trichotillomania and Excoriation Disorder: An Overview
Goldin, D. S., Salani, D. A., & Valdes, B. (2025) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20250506-04 · Cited by 2
Kim, S. G., Yoon, D.-J., Varias, D. C., Ahn, G. J., Han, G. U., Moon, S., Lee, H., Shin, S. H., & Ryu, B. (2025) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2025.106486 · Cited by 2
Baer, M. M., Keller, E., Ana, E. J. S., Stecker, T. A., Flanagan, J. C., Gray, K. M., & Back, S. E. (2026) · Psychology of Addictive Behaviors · doi:10.1037/adb0001095 · Cited by 2
Self-citationWang, H., Chen, X., Hu, D., Xin, X., Zhao, Z., & Jiang, Z. (2024) · Neuroreport · doi:10.1097/wnr.0000000000002109 · Cited by 2
Lopes, A. R., da Costa-Silva, D. G., Rodrigues, N. R., Martins, I. K., Leandro, L. P., Nunes, M. E. M., Posser, T., & Franco, J. L. (2024) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2024.2337366 · Cited by 2
Current Trends, Challenges for Research, and Therapeutic Perspectives in Nutritional Psychiatry
Vasiliu, O., Mangalagiu, A. G., Petrescu, B. M., Pleșa, C. F., Ungureanu, D., Micloș, M., Florescu, C., Draghici, A. I., Năstase, C., & Sîrbu, C. A. (2024) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2024.127.2.6 · Cited by 2
Schuch, J. B., Hansen, F., Hartmann, T., Bumaguin, D. B., Gomes, H. M., Moreira, J. C. F., Pechansky, F., Kessler, F. H. P., Galland, F., Silvello, D., et al. (2024) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2024-3541 · Cited by 2
Tye, S. J., & Cullen, K. R. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02230-z · Cited by 2
Treatment of Cocaine and Methamphetamine Use Disorders
Wolkowicz, N. R., Schwartz, E. K. C., MacLean, R. R., & Sofuoglu, M. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00704-0 · Cited by 1
Nelson-Goedert, N. (2026) · Swiss Archives of Neurology Psychiatry and Psychotherapy · doi:10.3390/sanpp176020009 · Cited by 1
Shariatmadari, H., Bigdeli, M. R., Khaksar, S., & Vahidi, S. (2026) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000889 · Cited by 1
Sinigaglia, G., Fortunato, L. M., Grillo, M. L., & Partata, W. A. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2025e14382 · Cited by 1
Askari, S., Eghdami, S., Tavasoli, M., Shariat, S. V., Yarahmadi, M., Jolfaei, A. G., Shirazi, E., Esmaeeli, S. T., & Shalbafan, M. (2026) · Communications Medicine · doi:10.1038/s43856-026-01711-6 · Cited by 1
Morley, K. C., Arunogiri, S., Connor, J. P., Clark, P. J., Chatterton, M. L., Baillie, A., Slade, T. N., Berk, M., Lubman, D. I., & Haber, P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091631 · Cited by 1
Self-citationÇelik, Y. S., Okumuş, H. G., Kaşak, M., Okyar, G., Çimen, B., Öztürk, Y., Efe, A., & Erel, Ö. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02428-2 · Cited by 1
Novel targets for autism spectrum disorder: Recent developments, challenges, and future perspectives
Dwivedi, S., Tschang, M., Subburaman, A., Varghese, S., Reddy, S. V., Shukla, S., Pandey, S., Gupta, P., Sharma, P., Kewat, D. P., et al. (2026) · Research in Autism · doi:10.1016/j.reia.2026.202900 · Cited by 1
Бокша, И. С., Prokhorova, T. A., Savushkina, O. K., Терешкина, Е. Б., Vorobyeva, E. A., & Burbaeva, G. S. (2023) · Нейрохимия · doi:10.31857/s1027813323040088 · Cited by 1
Zhang, Z., Xiao, H., Li, Z., Lin, H., Wang, H., Qian, Z., & Fu, L. (2026) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250543 · Cited by 1
Dunbar, K. Y., Dali, G., DeMayo, M. M., Logge, W., Hurzeler, T. P., Kelly, C., Watt, J., Squeglia, L. M., Kirkland, A. E., Haber, P., et al. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70066 · Cited by 1
Li, K., Tang, S., Ding, J., Yang, Y., Chen, H., Jiang, Q., Wei, X., & Yang, J. (2026) · Aquaculture · doi:10.1016/j.aquaculture.2026.743949 · Cited by 1
星形胶质细胞在自闭症谱系障碍及相关综合征中的参与:证据,动物模型,机制以及治疗潜能
Cui, K., Jian, M., Yun-Wu, Z., & 厦门大学医学院神经科学研究所福建省神经退行性疾病及衰老研究重点实验室, 福. 厦. (2026) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2026.086 · Cited by 1
Zhang, Y. (2026) · American Journal of Translational Research · doi:10.62347/xtyg7368 · Cited by 1
Effects of N-acetyl-L-cysteine on sperm quality during chilled storage of Maguan hornless goat semen
Xu, H., Cao, M., Wang, Q., Ju, Y., Wang, X., Liu, Q., Zeng, T., & Chen, X. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347756 · Cited by 1
Udawant, P., Jain, N. P., Dalvi, P., Jain, U., Dube, D., Vadhane, P., & Patil, S. (2026) · Genetics and Molecular Research · doi:10.4238/h55c0e43 · Cited by 1
Mocelin, R., & Peroni, B. Z. (2024) · Research Square · doi:10.21203/rs.3.rs-5165376/v1 · Cited by 1
Cheung, N. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1856979
Miller, C. O. G. (2025) · Springer eBooks · doi:10.1007/978-3-032-13315-1_2
Complementary/Integrative Medicine Treatment and Prevention of Youth Psychosis
Bhatara, V. S., Daniel, J., Whitman, C., Vik, T., Bernstein, B., & Simkin, D. R. (2023) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.08.009
Murda, B. K. K., Nugroho, I. G. B. I., & Herdaetha, A. (2023) · JUXTA Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga · doi:10.20473/juxta.v14i22023.63-69
Promoting Mental Health and Stress Reduction
Geis, A., & Heyland, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_16
Mørch, N. J. S., Calderón, A. B., Kvamme, T. L., Donskov, J. G., Secher, D. K., Díaz-i-Calvete, J., Pediotidis-Maniatis, D., Zana, B., Durand, S., Rumi, B., et al. (2024) · medRxiv · doi:10.1101/2024.09.01.24312906
Natural Medications in Psychiatry
Smith, F. A., Ivkovic, A., & Mischoulon, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00058-8
Natural Medications in Psychiatry
Smith, F. A., Ivkovic, A., & Mischoulon, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11972-9.00008-9
Crispim, M. G. A. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Chitolina, R. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Fernández‐Rodríguez, S. (2023) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
The comorbidity of chronic pain and depression
Βουτσαρά, Μ. Ν., & Βουτσαρά, Μ. Ν. (2024) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.39871
Coricovac, D. E., Pînzaru, I., & Dehelean, C. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.01155-6
Sanmartín, K. B., Mendoza, K., Villizhañay, J. D. D., & Martínez, F. M. L. (2024) · Mediciencias UTA (Impresa)/Mediciencias UTA (En línea) · doi:10.31243/mdc.uta.v8i3.2337.2024
Liu, N., Liu, Y., Wang, X., Liu, M., Wang, Y., Feng, C., & Piao, M. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70268
Martínez Rubio, M. D. (2024) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia)
ABORDAGENS FARMACOLÓGICAS PARA O MANEJO DA ANSIEDADE EM PACIENTES COM ESQUIZOFRENIA
do Paraízo, J. L. M., do Carmo, J. V. F., Silva, L. R., Salgado, M. T. S. B., Carneiro, S. U. N., da Silva, M. S., Monteiro, M. J. D. S., Paulino, A., Ferreira, A. I. P. N., & de Andrade, A. N. (2025) · A R International Health Beacon Journal · doi:10.70779/arihbj.v2i5.325
A EFICÁCIA DO USO DE N-ACETILCISTEÍNA NO TRATAMENTO DE TRANSTORNOS COGNITIVOS
Branco, K. M. F. C., Silva, G. R. E., Filho, E. A. D. S., Vieira, I. A. B., da Ponte, C. H. F., da Silva, J. A. P., & Guimarães, I. W. (2024) · Revista Contemporânea · doi:10.56083/rcv4n12-282
N-acetylcysteine as an adjunct therapy on painful symptoms in low back: a case report
Sinigaglia, G., Fortunato, L. M., Horst, A., Frank, M., & Partata, W. A. (2025) · Cuadernos de Educación y Desarrollo · doi:10.55905/cuadv17n3-009
Frota, I. J. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Englund, A., Schillemans, T., Nordenskiöld, K. Y., Wallensten, J., Carlsson, A. V., & Wachtler, C. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121905
Metadata
- Authors
- Bradlow, R. C. J., Berk, M., Kalivas, P. W., Back, S. E., & Kanaan, R. A.
- Affiliations
- Eastern Health (AU)
- Barwon Health (AU)
- Medical University of South Carolina (US)
- The University of Melbourne (AU)
- Corresponding author
- Kanaan, Richard A.
- Venue
- CNS Drugs
- Published
- 2022-03-22
- Volume
- 36
- Issue
- 5
- Pages
- 451-482
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- PMC
- PMC9095537
- OpenAlex
- W4220730089
- Cited by
- 87
- References
- 192
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 26 · 2023: 18 · 2022: 6
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-04-28)
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0 (tdm)
- creativecommons.org/licenses/by-nc/4.0 (vor)
- Locations
- CNS Drugs (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Funders
- University of Melbourne
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- N-acetylcysteine, mental illness, antioxidant activity, anti-inflammatory activity, glutamate modulation, negative symptoms of schizophrenia, autism spectrum disorder, depression, obsessive-compulsive disorder, substance use disorders, neurodevelopmental disorders, bipolar disorder, anxiety disorders, chronic pain, adjuvant therapy, clinical trial evidence
- MeSH terms
- Acetylcysteine, Anxiety Disorders, Bipolar Disorder, Humans, Obsessive-Compulsive Disorder, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.